Track topics on Twitter Track topics that are important to you
Tyrosine Protein Kinase CSK C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 18.104.22.168 Tyrosineprotein kinase CSK also known as Cterminal Src kinase is an enzyme that, in humans, is encoded by the CSK gene. It plays an important role in the regulation of cell growth, differentiation, migration and immune response. It phosphorylates tyrosine residues located in the Cterminal tails of Srcfamily kinases SFKs. To inhibit SFKs, CSK is recruited to the plasma membrane via binding to transmembrane proteins or adapter proteins located near the plasma membrane. It suppresses signaling by various surface receptors including Tcell receptor TCR and Bcell receptor BCR.
Tyrosine Protein Kinase CSK C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 22.214.171.124 pipeline Target constitutes close to 14 molecules. Out of which approximately 7 molecules are developed by companies and remaining by the universities/institutes. The molecules developed by companies in PreRegistration, Phase III, Phase I, Preclinical and Discovery stages are 1, 2, 1, 2 and 1 respectively. Similarly, the universities portfolio in Preclinical and Discovery stages comprises 5 and 2 molecules, respectively. Report covers products from therapy areas Oncology, Cardiovascular, Central Nervous System, Dermatology, Immunology and Infectious Disease which include indications Breast Cancer, Melanoma, HighGrade Glioma, Ovarian Cancer, Solid Tumor, Actinic Solar Keratosis, Acute Lymphocytic Leukemia ALL, Acute Lymphoblastic Leukemia, Acute Myelocytic Leukemia AML, Acute Myeloblastic Leukemia, Adenocarcinoma, Adenocarcinoma Of The Gastroesophageal Junction, Arrhythmias, Bile Duct Cancer Cholangiocarcinoma, Blood Cancer, Chronic Myelocytic Leukemia CML, Chronic Myeloid Leukemia, Colon Cancer, Colorectal Cancer, Epithelial Ovarian Cancer, EpsteinBarr Virus HHV4 Infections, Esophageal Cancer, Fallopian Tube Cancer, Gallbladder Cancer, Gastric Cancer, Glioblastoma Multiforme GBM, Glioma, Head And Neck Cancer Squamous Cell Carcinoma, Hematological Tumor, Hepatocellular Carcinoma, Hormone Refractory Castration Resistant, AndrogenIndependent Prostate Cancer, Lung Adenocarcinoma, Lymphoma, Metastatic Biliary Tract Cancer, Metastatic Breast Cancer, Metastatic Colorectal Cancer, Mild Cognitive Impairment, Myocardial Infarction, Nasopharyngeal Cancer, NonSmall Cell Lung Cancer, Osteosarcoma, Peritoneal Cancer, Prostate Cancer, Psoriasis, Recurrent Glioblastoma Multiforme GBM, Renal Cell Carcinoma, Skin Cancer, SmallCell Lung Cancer, Stroke, Thrombosis, Thymoma Thymic Epithelial Tumor and Thyroid Cancer.
The latest report Tyrosine Protein Kinase CSK Pipeline Review, H1 2018, outlays comprehensive information on the Tyrosine Protein Kinase CSK C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 126.96.36.199 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action MoA, route of administration RoA and molecule type. It also reviews key players involved in Tyrosine Protein Kinase CSK C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 188.8.131.52 targeted therapeutics development with respective active and dormant or discontinued projects.
The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industryspecific third party sources.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
The report provides a snapshot of the global therapeutic landscape for Tyrosine Protein Kinase CSK C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 184.108.40.206
The report reviews Tyrosine Protein Kinase CSK C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 220.127.116.11 targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industryspecific sources
The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages
The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, RD brief, licensing and collaboration details other developmental activities
The report reviews key players involved in Tyrosine Protein Kinase CSK C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 18.104.22.168 targeted therapeutics and enlists all their major and minor projects
The report assesses Tyrosine Protein Kinase CSK C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 22.214.171.124 targeted therapeutics based on mechanism of action MoA, route of administration RoA and molecule type
The report summarizes all the dormant and discontinued pipeline projects
The report reviews latest news and deals related to Tyrosine Protein Kinase CSK C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 126.96.36.199 targeted therapeutics
Reasons to buy
Gain strategically significant competitor information, analysis, and insights to formulate effective RD strategies
Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage
Identify and understand the targeted therapy areas and indications for Tyrosine Protein Kinase CSK C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 188.8.131.52
Identify the use of drugs for target identification and drug repurposing
Identify potential new clients or partners in the target demographic
Develop strategic initiatives by understanding the focus areas of leading companies
Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
Devise corrective measures for pipeline projects by understanding Tyrosine Protein Kinase CSK C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 184.108.40.206 development landscape
Develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeNEXT ARTICLE
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...